These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 10100564)
1. Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo Osseo. Messori A; Bosi A; Bacci S; Laszlo D; Trippoli S; Locatelli F; Van Lint MT; Di Bartolomeo P; Amici A Bone Marrow Transplant; 1999 Mar; 23(5):489-95. PubMed ID: 10100564 [TBL] [Abstract][Full Text] [Related]
2. Event-free survival and cost-effectiveness in adult acute lymphoblastic leukaemia in first remission treated with allogeneic transplantation. Orsi C; Bartolozzi B; Messori A; Bosi A Bone Marrow Transplant; 2007 Oct; 40(7):643-9. PubMed ID: 17660839 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin's lymphoma. Messori A; Bonistalli L; Costantini M; Alterini R Bone Marrow Transplant; 1997 Feb; 19(3):275-81. PubMed ID: 9028558 [TBL] [Abstract][Full Text] [Related]
4. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO). Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F; Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A; Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030 [TBL] [Abstract][Full Text] [Related]
6. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant. Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013 [TBL] [Abstract][Full Text] [Related]
7. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Ringdén O; Labopin M; Gorin NC; Meloni G; Blaise D; Reiffers J; Carlson K; Fouillard L; Frassoni F Bone Marrow Transplant; 2000 May; 25(10):1053-8. PubMed ID: 10828865 [TBL] [Abstract][Full Text] [Related]
8. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460 [TBL] [Abstract][Full Text] [Related]
9. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. Reed SD; Anstrom KJ; Ludmer JA; Glendenning GA; Schulman KA Cancer; 2004 Dec; 101(11):2574-83. PubMed ID: 15493042 [TBL] [Abstract][Full Text] [Related]
11. Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), Italy. Uderzo C; Valsecchi MG; Balduzzi A; Rovelli A; Dini G; Miniero R; Locatelli F; Rondelli R; Arcese W; Andolina M; Messina C; Polchi P; Biagi E; Arrigo C; Silvestri D; Masera G; Bacigalupo A Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():25-7. PubMed ID: 8932793 [No Abstract] [Full Text] [Related]
12. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328 [TBL] [Abstract][Full Text] [Related]
13. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568 [TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy and bone marrow transplantation for acute leukemia]. Masaoka T Gan To Kagaku Ryoho; 1993 Feb; 20(2):194-9. PubMed ID: 8434956 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Seo EJ; Park CJ; Chi HS; Lee JS Bone Marrow Transplant; 2003 Oct; 32(8):835-42. PubMed ID: 14520431 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
17. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. Porter GA; Cantor SB; Walsh GL; Rusch VW; Leung DH; DeJesus AY; Pollock RE; Brennan MF; Pisters PW J Thorac Cardiovasc Surg; 2004 May; 127(5):1366-72. PubMed ID: 15115994 [TBL] [Abstract][Full Text] [Related]
19. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia. Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544 [TBL] [Abstract][Full Text] [Related]
20. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]